Evidence map›Paper›PMID 36827388›Full record

ArticlePloS one2023

The DNA binding domain and the C-terminal region of DNA Ligase IV specify its role in V(D)J recombination.

Vidyasagar Malashetty, Audrey Au, Jose Chavez, Mary Hanna, Jennifer Chu, Jesse Penna, Patricia Cortes

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vidyasagar MalashettyImmunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Audrey AuDepartment of Molecular, Cellular and Biomedical Sciences, City University of New York School of Medicine, City College of New York, New York, NY, United States of America.
Jose ChavezImmunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Mary HannaImmunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Jennifer ChuImmunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Jesse PennaImmunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Patricia CortesDepartment of Molecular, Cellular and Biomedical Sciences, City University of New York School of Medicine, City College of New York, New York, NY, United States of America.ORCID 0000-0002-5231-2255
Icahn School of Medicine at Mount Sinai · USCity College of New York · US

Funding

Mechanism and regulation of V(D)J repairR01AI080755 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CORTES, PATRICIA · 2009 to 2013
$1.6M
Artemis: Biochemical ,structural and functional analysisR01AI070532 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CORTES, PATRICIA · 2009 to 2010
$834k
NIAID NIH HHS R01 AI070532NIAID NIH HHS R01 AI080755
6 · The paper itself

Abstract

DNA Ligase IV is responsible for the repair of DNA double-strand breaks (DSB), including DSBs that are generated during V(D)J recombination. Like other DNA ligases, Ligase IV contains a catalytic core with three subdomains-the DNA binding (DBD), the nucleotidyltransferase (NTD), and the oligonucleotide/oligosaccharide-fold subdomain (OBD). Ligase IV also has a unique C-terminal region that includes two BRCT domains, a nuclear localization signal sequence and a stretch of amino acid that participate in its interaction with XRCC4. Out of the three mammalian ligases, Ligase IV is the only ligase that participates in and is required for V(D)J recombination. Identification of the minimal domains within DNA Ligase IV that contribute to V(D)J recombination has remained unresolved. The interaction of the Ligase IV DNA binding domain with Artemis, and the interaction of its C-terminal region with XRCC4, suggest that both of these regions that also interact with the Ku70/80 heterodimer are important and might be sufficient for mediating participation of DNA Ligase IV in V(D)J recombination. This hypothesis was investigated by generating chimeric ligase proteins by swapping domains, and testing their ability to rescue V(D)J recombination in Ligase IV-deficient cells. We demonstrate that a fusion protein containing Ligase I NTD and OBDs flanked by DNA Ligase IV DBD and C-terminal region is sufficient to support V(D)J recombination. This chimeric protein, which we named Ligase 37, complemented formation of coding and signal joints. Coding joints generated with Ligase 37 were shorter than those observed with wild type DNA Ligase IV. The shorter length was due to increased nucleotide deletions and decreased nucleotide insertions. Additionally, overexpression of Ligase 37 in a mouse pro-B cell line supported a shift towards shorter coding joints. Our findings demonstrate that the ability of DNA Ligase IV to participate in V(D)J recombination is in large part mediated by its DBD and C-terminal region.

Indexed as

DNA LigasesV(D)J RecombinationAnimalsDNADNA Ligase ATPMammalsMiceNucleotidesDNADNA Ligase ATPDNA LigasesNucleotides

Identifiers

PMID36827388
PMCPMC9956705
OpenAlexW4321766585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.